Similar Search Results

Sources of US longevity increase, 1960 - 1997

Lichtenberg, Frank R. - 2000

this paper we investigate whether an aggregate health production function can help to explain the annual time …-series behavior of U.S. longevity since 1960. We view longevity as the output of the health production function, and output … annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual data are …

Persistent link: https://www.econbiz.de/10011397757

The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries : a two-way fixed-effects analysis

Lichtenberg, Frank R. - 2019

There are two types of prescription drug cost offsets. The first type of cost offset - from prescription drug use - is primarily about the effect of changes in drug quantity (e.g. due to changes in out-of-pocket drug costs) on other medical costs. The second type of cost offset - the cost offset...

Persistent link: https://www.econbiz.de/10011987056

The benefits and costs of newer drugs : evidence from the 1996 medical expenditure panel survey

Lichtenberg, Frank R. - 2000

The nation's spending for prescription drugs has grown dramatically in recent years. Previous studies have shown that the replacement of older drugs by newer, more expensive, drugs is the single most important reason for this increase, but they did not measure how much of the difference between...

Persistent link: https://www.econbiz.de/10011397709